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INTRODUCTION
 Cortisol hormone contribute significantly to 
maintaining homeostasis particularly through 
their role in the regulation of the body’s adaptive 
response to stress, in the maintenance of body 
water, electrolyte balance, and in the control of 
blood pressure; The Adrenal cortex synthesizes the 
steroid hormones called glucocorticoids (cortisol), 
mineralocorticoids (aldosterone) and androgens 
in response to hypothalamic-pituitary-adrenal 
hormone stimulation via adrenocorticotrophin 
hormone (ACTH). The ACTH release cortisol in a 
pulsatile manner with approximately 7–15 episodes 
daily. The stimulation of cortisol release occurs 
within 15 minutes of the surge in ACTH.1
 In addition to being pulsatile, the release of 
cortisol also follows a circadian rhythm. Release of 
cortisol is greatest during early morning waking 
hours, with levels declining as the afternoon 
progresses. This has a direct impact on how cortisol 
values are interpreted according to the timing 
of blood sample collection. The release of ACTH 
from the anterior pituitary is regulated by the 
hypothalamus via corticotropin-releasing hormone 
(CRH). Cortisol inhibits the secretion of ACTH 
in a negative feedback regulation mechanism. 
This closely regulated circuit is referred to as the 
hypothalamic-pituitary-adrenal (HPA) axis.
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ABSTRACT
Objective: To determine 7-9 am serum cortisol less than 5mcg/dl is an independent reliable confirmatory 
test for the diagnosis of primary adrenal insufficiency (PAI).
Methods: A total of 164 patients who visited the outpatient or inpatient department of Aga Khan University 
Hospital from June 2011 to June 2017 were included for the study. All those patients whose levels came 
out less than 5mcg/dl were recruited for the study and they all underwent SST. Other demographic and 
laboratory data were also recorded.
Results: The sensitivity of morning cortisol for diagnosis of PAI is 100% if levels are <1mcg/dl and decreases 
to 71.88% if levels are up to 5mcg/dl. 
Conclusion: Morning cortisol is sensitive enough as an alternative to SST if levels are <1mcg/dl (100%). 
However, if the levels are increased from >1mcg/dl to <5 mcg/dl, the sensitivity decreases gradually from 
98% to 71%.
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 Primary adrenal insufficiency (PAI) or 
Addison’s disease is defined by the inability of 
the adrenal cortex to produce sufficient amount 
of glucocorticoids and/or mineralocorticoids2 is 
a potentially life-threatening condition due to the 
central role of these hormones in energy, salt, and 
fluid homeostasis.
 The symptoms of PAI are quite nonspecific 
and include generalized body weakness, fatigue, 
body aches, nausea, vomiting, abdominal pain, 
depression, and anxiety. As a result, the diagnosis 
is frequently delayed, resulting in a clinical 
presentation of acute life-threatening adrenal crisis.3
 PAI is a rare disease with a reported prevalence of 
about 100 to 140 cases per million and an incidence 
of 4:1,000,000 per year in Western societies; 
autoimmunity is the most common cause of PAI4-7, 
followed by infectious diseases such as tuberculosis, 
adrenalectomy, neoplasia, and various genetic 
causes.
 According to guidelines, primary adrenal 
insufficiency (PAI) is screened by 8am serum 
cortisol level and confirmed by ACTH stimulation 
test2, the sensitivity of this test for the diagnosis of 
PAI is 92%. As there is a lot of financial constraints 
in our country and there is often non-availability of 
cosyntropin. Our study aim is to establish whether 
7-9am cortisol less than five is an independent 
reliable confirmatory test for the diagnosis of 
primary adrenal insufficiency.
METHODS
 This retrospective study was conducted at 
Department of Medicine in collaboration with 
section of Chemical Pathology, Department of 
Pathology & Laboratory Medicine, Aga Khan 
University Hospital (AKUH), and Karachi, Pakistan 
from June 2011 to June 2017. Study was commenced 
after taking approval from institution’s ethical 
review committee (ERC). All patients with cortisol 
level of less than 5mcg/dl that underwent ACTH 
stimulation test at AKUH laboratory were included. 
Patient admitted in intensive care unit (ICU) 
were excluded. Cut off used was post synacthen 
stimulation was more than 20mcg/dl.
Data analysis: Descriptive analysis consisted 
of reporting mean with standard deviation 
(for symmetrically distributed variables) or median 
with interquartile range (for asymmetrically 
distributed variables) for quantitative (continuous) 
variables such as age, cortisol levels at baseline, 0 
minutes and 60 minutes post synacthen injections. 
Frequency with percentages was reported for all 
categorical variable such as gender. Chi-square test 
was used to compare proportions across categories 
(0 mcg/dl to 5 mcg/dl) for adrenal insufficiency. 
Two sample paired t-test was used to compare 
pre and post short synacthen tests. The variable of 
baseline cortisol level was divided into six categories 
(0 to <1 mcg/dl, l to <2 mcg/dl, 2 to <3 mcg/dl, 3 
to <4 mcg/dl, 4 to <5 mcg/dl, 5 mcg/dl) while the 
variable of post short synacthen test was categorized 
into <20 mcg/dl and > 20 mcg/dl. Chi-square test 
was used to compare these two above mentioned 
variables. Moreover, proportions and percentages 
were also reported for each respective category. 
A p-value <0.05 was considered as statistically 
significant. All analyses were conducted using the 
Statistical package for Social Sciences SPSS (version 
19.0, copyright © SPSS; 1989-02).
RESULTS
 A total of 164 subjects were included in the study. 
The mean age of the subjects was 48±15.24 years. 
61% (n=100) of the subjects were female while 39% 
(n=64) being male.
 Mean baseline cortisol level before the synacthen 
test was 2.77±0.12mcg/dl. Mean cortisol level 
60 minutes after post-synacthen test was 
12.85±0.58mcg/dl. Mean difference between 
baseline cortisol and 60 minutes post-synacthen 
test was 10.075mcg/dl which was highly significant 
(p-value <0.001) (Table-I). 140 (85%) study 
participants had post-short synacthen cortisol 
level < 20mcg/dl while 24 (15%) of them had post-
synacthen cortisol level > 20 mcg/dl (Table–II).
 Out of the total study participants (11.5%) having 
baseline cortisol levels of 0 mcg/dl to <1mcg/dl 
with respect to post-synacthen stimulation test after 
sixty minutes were 100% (n=19) which showed 
Table-I: Pre & post short synacthen tests 
(two sample paired t-test).
S.  Variables Mean±S.D Mean p-value
No.   Difference
1. Baseline cortisol 2.77±0.12 10.075 < 0.001
    level
2. Post synacthen 12.85±0.58
    cortisol level
Table-II: Post-short synacthen cortisol level on 
stimulation with Tetracosynacthen (ACTH) 
after 60 mins as per standard guidelines2.
S. No. Post-short synacthen cortisol levels No. (%)
1. < 20 mcg/dl 140 (85%)
2. ≥20 mcg/dl 24 (15%)
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inadequate response. Moreover, 27.4% (n=45) of 
the total study participants had baseline cortisol 
level of 1 mcg/dl to < 2mcg/dl, while 97.7% (n=44) 
had post-synacthen stimulation test as inadequate 
response after sixty minutes and 2.2% (n=1) 
showed normal response after sixty minutes of the 
same category. Out of the total study participants, 
14.6 % (n=24) had baseline cortisol levels of 2 mcg/
dl to < 3mcg/dl, among them 83.3% (n=20) subjects 
showed inadequate response while 16.6% (n=4) 
showed normal response after sixty minutes. In 
the category of baseline cortisol levels of 3 mcg/dl 
to < 4mcg/dl, 16.4 % (n=27) of total study subjects 
were falling in the same range, among them 81.4% 
(n=22) had post-synacthen stimulation test as 
inadequate response after sixty minutes while 
18.5% (n=5) showed normal response after sixty 
minutes. Moreover, 19.5% (n=32) of the total study 
subjects had baseline cortisol levels of 4mcg/dl to 
< 5mcg/dl, among them, 71.8% (n=23) had post-
synacthen stimulation as inadequate response, 
while 28% (n=9) showed normal response after 
sixty minutes. Lastly, 10.6% (n=17) of the total 
study subjects had a baseline cortisol level of 5mcg/
dl, among them 70.5% (n=12) had post-synacthen 
stimulation as inadequate response after sixty 
minutes while 29% (n=5) showed normal response 
after sixty minutes. Overall, chi-square test p-value 
is highly significant (p-value <0.001) for this table 
(Table-III). In addition to this, cross-tabulation 
of gender and post-synacthen cortisol level was 
statistically insignificant (p-value = 0.72).
DISCUSSION
 In this study we have demonstrated that a 
morning cortisol value which can be used reliably 
as an alternative to SST for the diagnosis of PAI is 
≤1 mcg/dl (100% sensitivity). As morning cortisol 
values increases from ≥1mcg/dl to ≤5 mcg/dl it 
reduces the sensitivity of basal cortisol compared 
to SST from 98% to 71% respectively. Our study 
did not show any association of gender with 
post SST tests. Age difference between groups 
was also not statistically significant. Our data 
slightly differs from Endocrine Society Practice 
guidelines for Adrenal Insufficiency where a 
morning cortisol value of 3mcg/dl is a reliable 
cut off for diagnosing PAI2.
 There are studies favoring strong correlation 
between morning cortisol and response to 
Synacthen administration but there is a lack of local 
data which could be applied on our population.8
 The SST at a conventional dose of 250 mcg has 
been validated against the “gold standard” insulin 
tolerance test (ITT) for diagnosing suspected AI but 
there are significant challenges to the use of SST in 
clinical practice including availability of nursing 
staff, time to perform this test, financial constraints 
and shortage of synacthen in Pakistan therefore the 
utility of an alternative test to this dynamic testing 
cannot be denied.9
 In western countries where tuberculosis is not 
endemic the autoimmune Adrenalitis remains 
the leading cause of PAI and therefore requires 
a validated assay of auto-antibodies against 
21-hydroxylase followed by other tests if the 
antibody screening is negative thus excluding other 
causes.2 In Pakistan Tuberculosis is still considered 
as one of the most common causes of PAI.10
 The need for introducing dynamic testing 
for diagnosing PAI has been due to the broad 
range of morning cortisol value i.e. 5–25ug/dL 
(139–695nmol/L) as the serum cortisol can be 
affected by stress, exercise and food intake3, thus 
with chances of missing the borderline cases of 
PAI unless a strong clinical suspicion of adrenal 
insufficiency. The lack of uniformity in these cut-
off levels could in part be credited to differences 
in study populations, variability of dynamic tests, 
the use of different serum cortisol assays and 
dissimilar cut-off peak serum cortisol response 
indicative of a normal axis response and the 
difference in the clinical context in which the 
studies were done. Therefore, Laboratories have 
Diagnosis of primary adrenal insufficiency
Table-III: Baseline cortisol levels and post-synacthen cortisol levels.
S. No. Baseline cortisol Post-synacthen cortisol  Post-synacthen cortisol after 
	 level	mcg/dl	 after	60	min	<20	mcg/dl	no.	(%)	 60	min	≥20	mcg/dl	no.	(%)
1. 0 to <1 19 (100) 0 (0.00)
2. 1 to < 2 44 (97.78) 1 (2.22)
3. 2 to <3 20 (83.33) 4 (16.67)
4. 3 to <4 22 (81.48) 5 (18.52)
5. 4 to <5 23 (71.88) 9 (28.13)
6. 5 12 (70.59) 5 (29.41)
Pak J Med Sci     September - October  2019    Vol. 35   No. 5      www.pjms.org.pk     1416
to enforce the need to establish reference values 
for given populations, both for basal or stimulated 
hormone levels.11
 In a meta-analysis of 12 studies (635 subjects), a 
basal cortisol level less than 5 μg/dl (138 nmol/liter) 
best predicted PAI, whereas values greater than 
13 μg/dl (365 nmol/liter) best predicted normal 
Hypothalamic Pituitary Axis testing hypothalamic-
pituitary adrenal insufficiency.12
 Woods et al in a study of patients with adrenal 
suppression showed lower cut off values in patients 
exposed to steroids. A cortisol value of <1.2mcg/
dL (<34 nmol/l) having 100% sensitivity for failing 
an SST and values >12.6 mcg/dL with 100% 
specificity for passing SST (HPA axis recovery.) 
thus concluding that using these cut offs 50% of 
SSTs were performed unnecessarily on patients on 
inhaled glucorticoids.13
 The utility of SST for diagnosing PAI cannot 
be denied although its role in central adrenal 
insufficiency is still debatable.14 But an alternative 
and simple method of predicting the adrenal 
cortisol reserves by a morning cortisol level can 
avoid unnecessary SST testing thus avoiding cost 
issues and the non-availability of synacthan in 
different low socioeconomic countries.
 We do understand that this is a small data sample 
and will require further validation by carrying 
out similar trials in other tertiary care centers in 
Pakistan but once a consensus is reached regarding 
the morning basal cortisol cut off values at which 
PAI can be diagnosed in our population, we can 
avoid unnecessary SSTs.
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